BioSpace News Archive

Pharming Group N.V. announces that Pharming’s management will attend the following investor conferences in the month of June.

Philogen S.p.A. announces the publication of the latest results of Fibromun in combination with lomustine for the treatment of glioblastoma in Science Translational Medicine describing how the combination treatment cured orthotopic glioma-bearing mice and mediated durable objective responses and major tumor shrinkage in patients with recurrent glioblastoma.

ISA Pharmaceuticals B.V. announces that it will present the first clinical data of the combination of ISA101b and Regeneron’s PD-1 inhibitor Libtayo® in patients with recurrent metastatic Human Papilloma Virus type 16 induced head and neck cancers who progressed on pembrolizumab or nivolumab.

Alpha Teknova, Inc. announced that the Company will present and host individual and small group meetings at the following upcoming investor conference:

Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced oral and poster presentations during the upcoming Chemical Computing Group meetings:

Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, announced the appointment of Percival Barretto-Ko to the company’s Board of Directors.

Inotiv, Inc. announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will present at the Jefferies Healthcare Conference, being held in New York, NY, from June 7-9, 2023.

Standard BioTools Inc. announced that President and Chief Executive Officer Michael Egholm, PhD, will give a presentation at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 9:00 a.m. ET.